• 2008: hVIVO Year in Review: Milestones, Growth and 2025 Ambitions

  • 2024/12/20
  • 再生時間: 9 分
  • ポッドキャスト

2008: hVIVO Year in Review: Milestones, Growth and 2025 Ambitions

  • サマリー

  • In our recent interview with Mo Khan, CEO of hVIVO, we reflected on the company’s outstanding achievements in 2024 and gained insights into its ambitious roadmap for 2025. Under Mo’s leadership, hVIVO has solidified its position as a global leader in human challenge trials, achieving record revenues, expanding its client base, and leveraging its cutting-edge clinical trial models to accelerate drug and vaccine development.
    続きを読む 一部表示

あらすじ・解説

In our recent interview with Mo Khan, CEO of hVIVO, we reflected on the company’s outstanding achievements in 2024 and gained insights into its ambitious roadmap for 2025. Under Mo’s leadership, hVIVO has solidified its position as a global leader in human challenge trials, achieving record revenues, expanding its client base, and leveraging its cutting-edge clinical trial models to accelerate drug and vaccine development.

2008: hVIVO Year in Review: Milestones, Growth and 2025 Ambitionsに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。